Skip to content. | Skip to navigation

Personal tools
Log in
You are here: Home Life Sciences Center Amsterdam

gesubsidieerd door EFRO

Life Sciences Center Amsterdam

The Life Sciences Center Amsterdam is your point of entry to innovative technologies from: Academical Medical Center Amsterdam (AMC), University of Amsterdam (UvA), VU University & VU University medical center (VU & VUmc), Sanquin and Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL).

Europe invests in your future via the European Fund for Regional Development

The opportunities listed are available for technology transfer. If you require further information on any of them, please contact the LSCA office or contact Prof. Dr. Ada Kruisbeek, Director Life Sciences Center Amsterdam at kruisbeek[at]tto.vu.nl or Drs. Robert Jan Lamers, Associate Director Life Sciences Center Amsterdam at r.j.lamers[at]uva.nl.

Contact information:
Ingrid van Es
Project Manager Life Sciences Center Amsterdam (LSCA)
Science Park 904, B0.160
1098 XH Amsterdam
T +31 (0)20 525 2092
E y.t.vanes[at]lscamsterdam.nl or info[at]lscamsterdam.nl

LSCA technologies available for licensing are divided into a number of groups as listed.

Licensing Opportunities

Oncology

Barrett's Esophagugus Cancer Biobank

AMC
Zymogen Protein C: Cancer Treatment AMC
Improved cancer treatment AMC
Compounds against melanoma AMC
Breaking the boundaries for antibody therapy against cancer Sanquin
Bioluminescence imaging of tumor growth VUmc

Infectious diseases & Immunology

Booster of immune response and antibody production AMC
UCA derivatives as anti inflammatory agents AMC
Enhanced efficacy of RA treatment with a novel genotyping predictor test for IgG receptors Sanquin
Improved detection of copy number variation and SNPs Sanquin

CNS

Follow drug action in CNS with MRI AMC
microRNAs at the blood-brain barrier VUmc
Deep Brain Stimulation UvA
Temporal Lobe Epilepsy (TLE) UvA

Cardiovascular diseases

Biomarkers for restenosis risk assessment AMC
In vivo imaging unstable plaques AMC
Risk stratification biomarkers Arrhytmia AMC
Abl-related gene for endothelial barrier dysfunction VUmc

Collaborative and tailormade research projects

Acceleration of the development of new vaccines Sanquin

Other

Autotaxine inhibitor for treatment of itch AMC
Ultra specific labeling alternative for GFP AMC
New treatment for Port Wine Stains AMC
SURgical PAtient Safety System (SURPASS) AMC
Increasing the therapeutic efficacy of IgG Sanquin
Druglevel and Immunogenicity tests Sanquin
Accelerated wound healing with histatin VUmc
Optimized biomass production for cellular culture VUmc
Endocrine signalling in insulin release VUmc
Dedicated R&D genomics support UvA
Multifunctional catheter UvA

 

Download brochure Life Sciences in Business here.

Document Actions

Find your life sciences partner in the Amsterdam BioMed Cluster

Find your life sciences partner in the Amsterdam BioMed Cluster

Column

Penny-wise!

Synaps bij column Arjen Brussaard, foto CNCR.nl

By Arjen Brussaard

Recently the topsector plan Life Sciences & Health was published and presented to Minister Verhagen, of the so-called ELI Ministry. The document is an amazing compressed 60-pager, based on months of hard work by the group of experts chaired by Roel Fonville, and summarizes the conclusions after dozens of 1-to-1 meetings, five regional group sessions with dozens of opinion leaders and after having received over 170 (!) memo's, white papers and letters of intent.
More...

BES12 apply banner